REFERENCES
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49.
3. Azzoli CG. Practical value of molecular pathology in stage I-III lung cancer: implications for the clinical surgeon. Ann Surg Oncol. 2015;22:3459-65.
4. Eby ME, Seder CW. The landmark series: multimodality therapy for stage 3a non-small cell lung cancer. Ann Surg Oncol. 2020;27:3030-6.
5. Kocher F, Hilbe W, Seeber A, et al. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry. Lung Cancer. 2015;87:193-200.
6. de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503-13.
7. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
8. Christensen NL, Jekunen A, Heinonen S, Dalton SO, Rasmussen TR. Lung cancer guidelines in Sweden, Denmark, Norway and Finland: a comparison. Acta Oncol. 2017;56:943-8.
9. Stokstad T, Sørhaug S, Amundsen T, Grønberg BH. Reasons for prolonged time for diagnostic workup for stage I-II lung cancer and estimated effect of applying an optimized pathway for diagnostic procedures. BMC Health Serv Res. 2019;19:679.
10. Bukhari A, Kumar G, Rajsheker R, Markert R. Timeliness of lung cancer diagnosis and treatment. fed pract. 2017;34:24S-9S.
11. Banks KC, Dusendang JR, Schmittdiel JA, et al. Association of surgical timing with outcomes in early stage lung cancer. World J Surg. 2023;47:1323-32.
12. Kashiwabara K, Koshi S, Itonaga K, Nakahara O, Tanaka M, Toyonaga M. Outcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor. Lung Cancer. 2003;40:67-72.
13. Postmus PE, Kerr KM, Oudkerk M, et al; ESMO Guidelines Committee. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv1-21.
14. Ghamati MR, Li WWL, van der Heijden EHFM, Verhagen AFTM, Damhuis RA. Surgery without preoperative histological confirmation of lung cancer: what is the current clinical practice? J Thorac Dis. 2021;13:5765-75.
15. Madariaga ML, Lennes IT, Best T, et al; MGH Pulmonary Nodule Clinic Collaborative. Multidisciplinary selection of pulmonary nodules for surgical resection: diagnostic results and long-term outcomes. J Thorac Cardiovasc Surg. 2020;159:1558-66.e3.
16. Labarca G, Aravena C, Ortega F, et al. Minimally invasive methods for staging in lung cancer: systematic review and meta-analysis. Pulm Med. 2016;2016:1024709.
17. Hürter T, Hanrath P. Endobronchial sonography: feasibility and preliminary results. Thorax. 1992;47:565-7.
18. Yasufuku K, Chiyo M, Sekine Y, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest. 2004;126:122-8.
19. Folch EE, Labarca G, Ospina-Delgado D, et al. Sensitivity and safety of electromagnetic navigation bronchoscopy for lung cancer diagnosis: systematic review and meta-analysis. Chest. 2020;158:1753-69.
20. Murgu SD. Robotic assisted-bronchoscopy: technical tips and lessons learned from the initial experience with sampling peripheral lung lesions. BMC Pulm Med. 2019;19:89.
21. Yarmus L, Akulian J, Wahidi M, et al; Interventional Pulmonary Outcomes Group (IPOG). A prospective randomized comparative study of three guided bronchoscopic approaches for investigating pulmonary nodules: the PRECISION-1 study. Chest. 2020;157:694-701.
22. Chen AC, Pastis NJ Jr, Mahajan AK, et al. Robotic bronchoscopy for peripheral pulmonary lesions: a multicenter pilot and feasibility study (BENEFIT). Chest. 2021;159:845-52.
23. Benn BS, Romero AO, Lum M, Krishna G. Robotic-assisted navigation bronchoscopy as a paradigm shift in peripheral lung access. Lung. 2021;199:177-86.
24. Agrawal A, Ho E, Chaddha U, et al. Factors associated with diagnostic accuracy of robotic bronchoscopy with 12-month follow-up. Ann Thorac Surg. 2023;115:1361-8.
25. Zhang C, Xie F, Li R, Cui N, Herth FJF, Sun J. Robotic-assisted bronchoscopy for the diagnosis of peripheral pulmonary lesions: a systematic review and meta-analysis. Thorac Cancer. 2024;15:505-12.
26. Novellis P, Bottoni E, Voulaz E, et al. Robotic surgery, video-assisted thoracic surgery, and open surgery for early stage lung cancer: comparison of costs and outcomes at a single institute. J Thorac Dis. 2018;10:790-8.
27. Kent MS, Hartwig MG, Vallières E, et al. Pulmonary open, robotic, and thoracoscopic lobectomy (PORTaL) study: an analysis of 5721 cases. Ann Surg. 2023;277:528-33.
28. Patel PP, Duong DK, Mahajan AK, Imai TA. Single setting robotic lung nodule diagnosis and resection. Thorac Surg Clin. 2023;33:233-44.
29. Wolf AJ, Miller PM, Burk JR, Vigness RM, Hollingsworth JW. Ability of single anesthesia for combined robotic-assisted bronchoscopy and surgical lobectomy to reduce time between detection and treatment in stage I non-small cell lung cancer. Proc. 2023;36:434-8.
30. Ross P, Skabla P, Sutter J, Meyer T. Fast track nodule pathway: same day robotic diagnosis and resection. Chest. 2021;160:A82.
31. Ross P, Skabla P, B Sutter J, T Whealon S, Ibrahim K, J Meyer T. Optimizing the resection pathway: can minimally invasive diagnosis and surgery (midas) guide patient selection? Chest. 2022;162:A1615.
32. Brownlee AR, Watson JJJ, Akhmerov A, et al. Robotic navigational bronchoscopy in a thoracic surgery practice: leveraging technology in the management of pulmonary nodules. JTCVS Open. 2023;16:1-6.
33. Heiden BT, Eaton DB Jr, Engelhardt KE, et al. Analysis of delayed surgical treatment and oncologic outcomes in clinical stage I non-small cell lung cancer. JAMA Netw Open. 2021;4:e2111613.
34. Na KJ, Park IK, Park S, Kang CH, Kim YT. Efficacy and cost-effectiveness of surgical biopsy for histologic diagnosis of indeterminate nodules suspected for early stage lung cancer: comparison with percutaneous needle biopsy. J Korean Med Sci. 2020;35:e261.
35. Wang X, Ma X, Yang M, et al. Proportion and related factors of depression and anxiety for inpatients with lung cancer in China: a hospital-based cross-sectional study. Support Care Cancer. 2022;30:5539-49.
36. Vodermaier A, Lucas S, Linden W, Olson R. Anxiety after diagnosis predicts lung cancer-specific and overall survival in patients with stage III non-small cell lung cancer: a population-based cohort study. J Pain Symptom Manage. 2017;53:1057-65.
37. Arrieta O, Angulo LP, Núñez-Valencia C, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2013;20:1941-8.
38. Daly CM, Scott JF, Bibee KP. Patient anxiety related to patient-perceived delays in surgical treatment of skin cancer. Dermatol Surg. 2023;49:352-4.
39. Torre M, Reda M, Musso V, Danuzzo F, Mohamed S, Conforti S. Diagnostic accuracy of endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) for mediastinal lymph node staging of lung cancer. Mediastinum. 2021;5:15.
40. Paech DC, Weston AR, Pavlakis N, et al. A systematic review of the interobserver variability for histology in the differentiation between squamous and nonsquamous non-small cell lung cancer. J Thorac Oncol. 2011;6:55-63.
41. Błach J, Frąk M, Krawczyk P, et al. Observational cross-sectional study of 5279 bronchoscopy results for the practical effectiveness of various biopsy techniques in the diagnosis of lung diseases with particular emphasis on lung cancer. BMJ Open. 2021;11:e043820.
42. Khan F, Seaman J, Hunter TD, et al. Diagnostic outcomes of robotic-assisted bronchoscopy for pulmonary lesions in a real-world multicenter community setting. BMC Pulm Med. 2023;23:161.
43. Ali MS, Ghori UK, Wayne MT, Shostak E, De Cardenas J. Diagnostic performance and safety profile of robotic-assisted bronchoscopy: a systematic review and meta-analysis. Ann Am Thorac Soc. 2023;20:1801-12.
44. Folch EE, Bowling MR, Pritchett MA, et al; NAVIGATE Study Investigators. NAVIGATE 24-month results: electromagnetic navigation bronchoscopy for pulmonary lesions at 37 centers in Europe and the United States. J Thorac Oncol. 2022;17:519-31.
45. Ali MS, Trick W, Mba BI, Mohananey D, Sethi J, Musani AI. Radial endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions: a systematic review and meta-analysis. Respirology. 2017;22:443-53.
46. Rocco G, Nason K, Brunelli A, Varela G, Waddell T, Jones DR. Management of stage IIIA (N2) non-small cell lung cancer: a transatlantic perspective. Ann Thorac Surg. 2016;101:1247-50.
47. Los Robles Health System. Los Robles Health System performs first single anesthetic procedure for lung cancer treatment. Available from https://losrobleshospital.com/about/newsroom/los-robles-health-system-performs-first-single-anesthetic-procedure-for-lung-cancer-treatment. [accessed 16 January 2025].
48. Loma Linda University Health. LLUH introduces a revolutionary single anesthesia procedure combining lung cancer diagnosis and removal. Available from https://news.llu.edu/patient-care/lluh-introduces-revolutionary-single-anesthesia-procedure-combining-lung-cancer-diagnosis-and-removal. [accessed 16 January 2025].
49. Wong AW, Wang EY, Fong A, et al. Streamlining care with single anesthetic robotic lung cancer diagnosis and resection. Curr Chall Thorac Surg. 2024;6:6-6.
50. Weill Cornell Medicine Cardiothoracic Surgery. Single anesthesia for combined robotic-assisted bronchoscopy and surgical lobectomy. Available from https://ctsurgery.weillcornell.org/single-anesthesia-event. [accessed 16 January 2025].
